18.02.2014 • News

Clariant Said to Plan Exit from ASK Joint Venture With Ashland

Clariant is seeking to unload its stake in ASK Chemicals, a 50:50 joint venture with U.S.-based chemical producer Ashland, according to unconfirmed reports.

People familiar with the transaction told the news agency Reuters that several companies are interested, including private equity investor Sun Capital. Offers would be accepted until the end of February, the reports said.

Based at Hilden, near Düsseldorf, Germany, the company with 1,800 employees produces binding agents and additives for the foundry sector. Clariant has operative control.

Analysts said ASK could be valued at six to seven times the expected 2013 EBITDA of €40 million, which would give the chemical producer an enterprise value of €240-280 million.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read